Risk stratification and validation of prostate specific antigen density as independent predictor of progression in men with low risk prostate cancer during active surveillance

Journal of Urology

Volumn 185, Issue 2, 2011, Pages 471-476

  San Francisco, Ignacio F ^a,c   Werner, Lillian ^b   Regan, Meredith M ^b   Garnick, Marc B ^a   Bubley, Glenn ^a   Dewolf, William C ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

biopsy; prostate; prostate specific antigen; prostatic neoplasms; risk

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FAMILY HISTORY; GENERAL PATHOLOGICAL PARAMETERS; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; RISK ASSESSMENT; VALIDATION STUDY;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; CONFIDENCE INTERVALS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK ASSESSMENT; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; WATCHFUL WAITING;

EID: 78651333293     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.09.115     Document Type: Article

References (17)

1. National Comprehensive Cancer Network Prostate Cancer Guideline v2, 2010 http://www.nccn.org Accessed August 26, 2010
2. L. Klotz, L. Zhang, and A. Lam Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer J Clin Oncol 28 2010 126
3. K.S. Tseng, P. Landis, and J.I. Epstein Risk stratification of men choosing surveillance for low risk prostate cancer J Urol 183 2010 1779
4. N.J. van As, A.R. Norman, and K. Thomas Predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance Eur Urol 54 2008 1297
5. M.S. Soloway, C.T. Soloway, and S. Williams Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience BJU Int 101 2008 165
6. A. Khatami, G. Aus, and J.E. Damber PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: results from the European Randomized Study of Screening for Prostate Cancer, Sweden Section Int J Cancer 120 2007 170
7. R.C. van denBergh, S. Roemeling, and M.J. Roobol Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly Eur Urol 55 2009 1
8. H.B. Carter, A. Kettermann, and C. Warlick Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience J Urol 178 2007 2359
9. J.I. Epstein, P.C. Walsh, and M. Carmichael Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer JAMA 271 1994 368
10. V. Ravery, S. Dominique, and X. Panhard The 20-core prostate biopsy protocola new gold standard? J Urol 179 2008 504
11. J. Kao, M. Upton, and P. Zhang Individual prostate biopsy core embedding facilitates maximal tissue representation J Urol 168 2002 496
12. J.I. Epstein, H. Sanderson, and H.B. Carter Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy Urology 66 2005 356
13. G. Ploussard, E. Xylinas, and L. Salomon The role of biopsy core number in selecting prostate cancer patients for active surveillance Eur Urol 56 2009 891
14. H.B. Carter, P.C. Walsh, and P. Landis Expectant management of nonpalpable prostate cancer with curative intent: preliminary results J Urol 167 2002 1231
15. C. Warlick, B.J. Trock, and P. Landis Delayed versus immediate surgical intervention and prostate cancer outcome J Natl Cancer Inst 98 2006 355
16. S.L. Conti, M. Dall'era, and V. Fradet Pathological outcomes of candidates for active surveillance of prostate cancer J Urol 181 2009 1628
17. A.S. Duffield, T.K. Lee, and H. Miyamoto Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails J Urol 182 2009 2274